Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The multicenter uveitis steroid treatment trial

Ophthalmology

Volumn 118, Issue 10, 2011, Pages 1916-1926

  Kempen, John H ^a,b   Altaweel, Michael M ^c   Holbrook, Janet T ^d   Jabs, Douglas A ^d,e   Louis, Thomas A ^d   Sugar, Elizabeth A ^d   Thorne, Jennifer E ^d,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUOCINOLONE ACETONIDE; PREDNISONE;

ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CONTROLLED STUDY; DIABETES MELLITUS; FRACTURE; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

DRUG IMPLANTS; DRUG THERAPY, COMBINATION; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACULAR EDEMA; MALE; MIDDLE AGED; PANUVEITIS; PREDNISONE; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UVEITIS, INTERMEDIATE; UVEITIS, POSTERIOR; VISUAL ACUITY; VISUAL FIELDS;

EID: 80053594211     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.07.027     Document Type: Article

References (36)

1. J. ten Doesschate Causes of blindness in The Netherlands Doc Ophthalmol 52 1982 279 285 (Pubitemid 12108052)
2. National Advisory Eye Council Program Planning Subcommittee Vision ResearchA National Plan: 1983-1987 Volume 1: The 1983 Report of the National Advisory Eye Council 1983 National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services Bethesda, MD 13 http://ia700402.us.archive.org/34/items/visionresearchna01nati/ visionresearchna01nati.pdf Accessed June 24, 2011
3. E. Bloch-Michel, and R.B. Nussenblatt International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease Am J Ophthalmol 103 1987 234 235
4. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516
5. O.M. Durrani, N.N. Tehrani, and J.E. Marr Degree, duration, and causes of visual loss in uveitis Br J Ophthalmol 88 2004 1159 1162 (Pubitemid 39141376)
6. A. Rothova, M.S. Suttorp-van Schulten, W. Frits Treffers, and A. Kijlstra Causes and frequency of blindness in patients with intraocular inflammatory disease Br J Ophthalmol 80 1996 332 336 (Pubitemid 26113585)
7. O.M. Durrani, C.A. Meads, and P.I. Murray Uveitis: a potentially blinding disease Ophthalmologica 218 2004 223 236 (Pubitemid 38969828)
8. D.A. Jabs, J.T. Rosenbaum, and C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 2000 492 513
9. D.G. Callanan, G.J. Jaffe, and D.F. Martin Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results Arch Ophthalmol 126 2008 1191 1201
10. G.J. Jaffe, D. Martin, D. Callanan Fluocinolone Acetonide Uveitis Study Group Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 113 2006 1020 1027 (Pubitemid 43795240)
11. G.J. Jaffe, J. Ben Nun, and H. Guo Fluocinolone acetonide sustained drug delivery device to treat severe uveitis Ophthalmology 107 2000 2024 2033
12. Multicenter Uveitis Steroid Treatment Trial Research Group The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics Am J Ophthalmol 149 2010 550 561
13. C. Pavesio, M. Zierhut, K. Bairi Fluocinolone Acetonide Study Group Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis Ophthalmology 117 2010 567 575
14. F.L. Ferris III, and I. Bailey Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum Ophthalmology 103 1996 181 182 (Pubitemid 26046177)
15. B. Bengtsson, and A. Heijl Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies Acta Ophthalmol Scand 77 1999 143 146 (Pubitemid 29164050)
16. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058 (Pubitemid 32652197)
17. J.E. Brazier, R. Harper, and N.M. Jones Validating the SF-36 health survey questionnaire: new outcome measure for primary care BMJ 305 1992 160 164
18. C. Jenkinson, L. Wright, and A. Coulter Criterion validity and reliability of the SF-36 in a population sample Qual Life Res 3 1994 7 12 (Pubitemid 24062654)
19. EuroQol Group EuroQola new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
20. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816 (Pubitemid 40051904)
21. Verteporfin in Photodynamic Therapy (VIP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trialVIP report no. 1 Ophthalmology 108 2001 841 852
22. S.S. Ellenberg, T.R. Fleming, and D.L. DeMets Statistical, Philosophical, and Ethical Issues in Data Monitoring S.S. Ellenberg, T.R. Fleming, D.L. DeMets, Data Monitoring Committees in Clinical Trials: A Practical Perspective 2002 Wiley Chichester, UK 126 128
23. P.C. O'Brien, and T.R. Fleming A multiple testing procedure for clinical trials Biometrics 35 1979 549 556 (Pubitemid 10242750)
24. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
25. R.J. Little, and D.B. Rubin Statistical Analysis with Missing Data 2nd ed. 2002 Wiley Hoboken, NJ 85 89
26. R.D. Hays, and L.S. Morales The RAND-36 measure of health-related quality of life Ann Med 33 2001 350 357 (Pubitemid 32675376)
27. I.J. Suner, G.T. Kokame, and E. Yu Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials Invest Ophthalmol Vis Sci 50 2009 3629 3635
28. A.S. Pickard, M.P. Neary, and D. Cella Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes [serial online] 5 2007 70 http://www.hqlo.com/content/5/1/70 Accessed June 24, 2011
29. G.J. Jaffe, R.M. McCallum, and B. Branchaud Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis Ophthalmology 112 2005 1192 1198
30. R.O. Kacmaz, J.H. Kempen, C. Newcomb Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group Ocular inflammation in Behet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 2008 828 836
31. J.E. Thorne, F. Woreta, and S.R. Kedhar Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss Am J Ophthalmol 143 2007 840 846
32. D.A. Goldstein, D.G. Godfrey, and A. Hall Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants Arch Ophthalmol 125 2007 1478 1485 (Pubitemid 350106679)
33. J.A. Da Silva, J.W. Jacobs, and J.R. Kirwan Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Ann Rheum Dis 65 2006 285 293 (Pubitemid 43268214)
34. V. Ravindran, S. Rachapalli, and E.H. Choy Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis Rheumatology (Oxford) 48 2009 807 811
35. R.A. Wise, S.J. Bartlett, E.D. Brown American Lung Association Asthma Clinical Research Centers Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers J Allergy Clin Immunol 124 2009 436 444
36. R. Wang, S.W. Lagakos, and J.H. Ware Statistics in medicinereporting of subgroup analyses in clinical trials N Engl J Med 357 2007 2189 2194